Literature DB >> 16385240

Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis.

Katsutoshi Tokushige1, Etsuko Hashimoto, Noriko Tsuchiya, Hiroyuki Kaneda, Makiko Taniai, Keiko Shiratori.   

Abstract

BACKGROUND: Soluble tumor necrosis factor receptor (sTNFR) is reported to be a good indicator of TNF production and severity in inflammatory diseases. To investigate the clinical significance of sTNFR in non-alcoholic steatohepatitis (NASH), we measured the serum levels of soluble TNF receptor-1 and -2. PATIENTS AND METHODS: We analyzed 82 NASH patients and 15 healthy subjects (control). The grades of fibrosis, inflammation and fatty deposit were evaluated on liver biopsy. The serum levels of sTNFR-1 and -2 were measured by ELISA.
RESULTS: There was significant correlation between platelet count and sTNFRs. The titers of sTNFR-2 in NASH patients with diabetes mellitus (DM) were higher than in those without DM. The serum levels of sTNFRs in NASH patients with advanced fibrosis were increased compared with those of control and NASH patients with low-grade fibrosis. Soluble TNFRs in patients with moderate inflammation were increased compared to those of control and patients with mild inflammation. There was no significant association between fatty deposit grade and sTNFRs.
CONCLUSION: Soluble TNFRs have a significant correlation with fibrosis in NASH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385240     DOI: 10.1097/01.alc.0000191810.46000.37

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

1.  Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

Authors:  Wei Cui; Stephen L Chen; Ke-Qin Hu
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 2.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

3.  Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats.

Authors:  Satoshi Kajikawa; Tsuyoshi Harada; Akiko Kawashima; Kazunori Imada; Kiyoshi Mizuguchi
Journal:  Dig Dis Sci       Date:  2009-10-24       Impact factor: 3.199

Review 4.  Nonalcoholic fatty liver disease in children living in the obeseogenic society.

Authors:  H Hesham A-Kader
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

Review 5.  Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.

Authors:  Joeri Lambrecht; Frank Tacke
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

6.  Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II.

Authors:  Celeste Trejo-Moreno; Enrique Jiménez-Ferrer; Gabriela Castro-Martínez; Marisol Méndez-Martínez; María Angélica Santana; Gerardo Arrellín-Rosas; José Pedraza-Chaverri; Omar Noel Medina-Campos; Beatriz Hernández-Téllez; Oscar Ramírez-Pliego; Maribel Herrera-Ruiz; Jacquelynne Cervantes-Torres; Zimri Aziel Alvarado-Ojeda; Alejandro Costet-Mejía; Gladis Fragoso; Gabriela Rosas-Salgado
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.